Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-312-7 | CAS number: 105-59-9
No data on inhalation or oral absorption are available. Therefore, for the DNEL derivation the defaults as reported in the REACH guidance will be used (100% absorption for both routes).
The pharmacokinetics and tissue distribution of MDEA were studied in the Fischer 344 rat after a single intravenous (50 or 500 mg/kg bw) or cutaneous dose (500 mg/kg bw for 6 or 72 h contact; Leung et al, 1996). Topically applied MDEA was well absorbed by both male and female rats (17-21% and 41-50% after 6 and 72 h contact, respectively), after apparently being first sequestered in the skin and later slowly released into the bloodstream. Distribution of MDEA was relatively uniform throughout the major organs, with the highest concentrations being in the liver and kidney. MDEA was substantially metabolised. Metabolism of MDEA could be saturated at high dosages since nonlinear kinetic behavior was observed in rats dosed intravenously with 500 mg/kg bw. The predominant excretion route for MDEA was in the urine. Urinary excretion of MDEA was slow, with an excretion half-life in excess of 30 h following cutaneous dosing. Metabolites (not identified) constituted the major fraction in urine, indicating that metabolism plays an important role in MDEA elimination. Based on these results, a dermal absorption rate of 20% will be used for DNEL derivation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Close Do not show this message again